Drug ID: | NPD7548 |
Drug Name: | OT-4003 |
Molecular Formula: | C31H31ClN2O3 |
Canonical SMILES: | CCCCC[C@@H](C(=O)O)Oc1ccccc1CNc1cccc(c1)/C=C/c1ccc2c(n1)ccc(c2)Cl |
Standard InCHI: | InChI=1S/C31H31ClN2O3/c1-2-3-4-12-30(31(35)36)37-29-11-6-5-9-24(29)21-33-27-10-7-8-22(19-27)13-16-26-17-14-23-20-25(32)15-18-28(23)34-26/h5-11,13-20,30,33H,2-4,12,21H2,1H3,(H,35,36)/b16-13+/t30-/m0/s1 |
Standard InCHIKey: | ISSQAEFOGQDRLK-NXVZURFXSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB007610 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 514.20 |
ALogP | -0.8484 |
MLogP | 4.21 |
XLogP | 9.783 |
HDA | 4 |
HBD | 2 |
Rotatable Bonds | 15 |
TPSA | 71.45 |
RO5 Violation | 2 |